MCEWEN MINING INC (MUX)

US58039P3055 - Common Stock

11.76  +0.15 (+1.29%)

After market: 11.76 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MUX. MUX was compared to 154 industry peers in the Metals & Mining industry. MUX has a bad profitability rating. Also its financial health evaluation is rather negative. MUX has a valuation in line with the averages, but it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

In the past year MUX has reported negative net income.
In the past year MUX has reported a negative cash flow from operations.
MUX had negative earnings in 4 of the past 5 years.
MUX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

MUX's Return On Assets of 8.41% is amongst the best of the industry. MUX outperforms 85.06% of its industry peers.
MUX has a Return On Equity of 11.01%. This is amongst the best in the industry. MUX outperforms 81.17% of its industry peers.
Industry RankSector Rank
ROA 8.41%
ROE 11.01%
ROIC N/A
ROA(3y)-5.91%
ROA(5y)-11.53%
ROE(3y)-9.74%
ROE(5y)-16.57%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 33.26%, MUX belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
MUX's Gross Margin of 11.05% is in line compared to the rest of the industry. MUX outperforms 42.86% of its industry peers.
MUX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 33.26%
GM 11.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-15.64%

2

2. Health

2.1 Basic Checks

MUX does not have a ROIC to compare to the WACC, probably because it is not profitable.
MUX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MUX has been increased compared to 5 years ago.
The debt/assets ratio for MUX has been reduced compared to a year ago.

2.2 Solvency

MUX has an Altman-Z score of -0.67. This is a bad value and indicates that MUX is not financially healthy and even has some risk of bankruptcy.
MUX has a worse Altman-Z score (-0.67) than 83.12% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that MUX is not too dependend on debt financing.
MUX has a better Debt to Equity ratio (0.08) than 62.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC7.74%

2.3 Liquidity

MUX has a Current Ratio of 1.76. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.76, MUX is doing worse than 65.58% of the companies in the same industry.
MUX has a Quick Ratio of 1.09. This is a normal value and indicates that MUX is financially healthy and should not expect problems in meeting its short term obligations.
MUX has a Quick ratio of 1.09. This is in the lower half of the industry: MUX underperforms 62.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.09

3

3. Growth

3.1 Past

MUX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.72%.
Looking at the last year, MUX shows a very strong growth in Revenue. The Revenue has grown by 50.54%.
The Revenue has been growing slightly by 5.33% on average over the past years.
EPS 1Y (TTM)-37.72%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q32.5%
Revenue 1Y (TTM)50.54%
Revenue growth 3Y16.62%
Revenue growth 5Y5.33%
Revenue growth Q2Q107.79%

3.2 Future

The Earnings Per Share is expected to grow by 84.33% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y143.38%
EPS Next 2Y84.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

MUX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.79, which indicates a very decent valuation of MUX.
Based on the Price/Forward Earnings ratio, MUX is valued cheaper than 81.82% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.88. MUX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 11.79

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MUX's earnings are expected to grow with 84.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MUX!.
Industry RankSector Rank
Dividend Yield N/A

MCEWEN MINING INC

NYSE:MUX (5/3/2024, 7:07:45 PM)

After market: 11.76 0 (0%)

11.76

+0.15 (+1.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap581.41M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.79
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.41%
ROE 11.01%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 33.26%
GM 11.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.76
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-37.72%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y143.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)50.54%
Revenue growth 3Y16.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y